Genetic and Biochemical Characterization of Halogenation and Drug Transportation Genes Encoded in the Albofungin Biosynthetic Gene Cluster
Albofungin, a natural product produced from Streptomycetes, exhibits bioactivities against bacteria, fungi, and tumor cells. The biosynthetic logic, regulations, and resistance of albofungin remain yet to be addressed. Albofungin, a hexacyclic aromatic natural product, exhibits broad-spectrum antimi...
Saved in:
Published in | Applied and environmental microbiology Vol. 88; no. 17; pp. 1 - 20 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
1752 N St., N.W., Washington, DC
American Society for Microbiology
13.09.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Albofungin, a natural product produced from Streptomycetes, exhibits bioactivities against bacteria, fungi, and tumor cells. The biosynthetic logic, regulations, and resistance of albofungin remain yet to be addressed.
Albofungin, a hexacyclic aromatic natural product, exhibits broad-spectrum antimicrobial activity. Its biosynthesis, regulation, and resistance remain elusive. Here, we report the albofungin (
abf
) biosynthetic gene cluster (BGC) from its producing strain
Streptomyces tumemacerans
JCM5050. The nascent
abf
BGC encodes 70 putative genes, including regulators, transporters, type II polyketide synthases (PKSs), oxidoreductase, and tailoring enzymes. To validate the intactness and functionality of the BGC, we developed an
Escherichia coli
-
Streptomyces
shuttle bacterial artificial chromosome system, whereby the
abf
BGC was integrated into the genome of a nonproducing host via heterologous conjugation, wherefrom albofungin can be produced, confirming that the BGC is in effect. We then delimited the boundaries of the BGC by means of
in vitro
CRISPR-Cas9 DNA editing, concluding a minimal but essential 60-kb
abf
BGC ranging from
orfL
to
abf58
. The
orfA
gene encoding a reduced flavin adenine dinucleotide (FADH
2
)-dependent halogenase was examined and is capable of transforming albofungin to halogen-substituted congeners
in vivo
and
in vitro
. The
orfL
gene encoding a transporter was examined
in vivo
. The presence/absence of
orfA
or
orfL
demonstrated that the MIC of albofungin is subject to alteration when an extracellular polysaccharide intercellular adhesin was formed. Despite that halogenation of albofungin somewhat increases binding affinity to transglycosylase (TGase), albofungin with/without a halogen substituent manifests similar
in vitro
antimicrobial activity. Halogenation, however, limits overall dissemination and effectiveness given a high secretion rate, weak membrane permeability, and high hydrophobicity of the resulting products, whereby the functions of
orfA
and
orfL
are correlated with drug detoxification/resistance for the first time.
IMPORTANCE
Albofungin, a natural product produced from Streptomycetes, exhibits bioactivities against bacteria, fungi, and tumor cells. The biosynthetic logic, regulations, and resistance of albofungin remain yet to be addressed. Herein, the minimal albofungin (
abf
) biosynthetic gene cluster (BGC) from the producing strain
Streptomyces tumemacerans
JCM5050 was precisely delimited using the
Escherichia coli
-Streptomyces
shuttle bacterial artificial chromosome system, of which the gene essentiality was established
in vivo
and
in vitro
. Next, we characterized two genes
orfA
and
orfL
encoded in the
abf
BGC, which act as a reduced flavin adenine dinucleotide (FADH
2
)-dependent halogenase and an albofungin-congeners transporter, respectively. While each testing microorganism exhibited different sensitivities to albofungins, the MIC values of albofungins against testing strains with/without
orfA
and/or
orfL
were subject to considerable changes. Halogen-substituted albofungins mediated by OrfA manifested overall compromised dissemination and effectiveness, revealing for the first time that two functionally distinct proteins OrfA and OrfL are associated together, exerting a novel “belt and braces” mechanism in antimicrobial detoxification/resistance. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 The authors declare no conflict of interest. Zhe-Chong Wang and I-Wen Lo contributed equally to this work. Zhe-Chong Wang and I-Wen Lo implemented the genetic and biochemical portions of the work, respectively. |
ISSN: | 0099-2240 1098-5336 1098-5336 |
DOI: | 10.1128/aem.00806-22 |